"Cost-Minimization and Budget Impact Analysis of Rituximab SC VS Rituximab IV for Non-Hodgkin’s Lymphoma (NHLs) in Greece"
written by Dionysis Kyriopoulos, Vasiliki Tsiantou, Labrini Papageorgiou, Fani Theodoropoulou, Kostas Athanasakis,
published by Journal of Cancer Therapy, Vol.8 No.8, 2017
has been cited by the following article(s):
  • Google Scholar
  • CrossRef